Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

translational research

This page shows the latest translational research news and features for those working in and with pharma, biotech and healthcare.

Merck & Co signs deal with Amathus for neurodegeneration diseases

Merck & Co signs deal with Amathus for neurodegeneration diseases

head of discovery sciences and translational medicine, Merck Research Laboratories.

Latest news

  • UK biotech Synairgen to begin COVID-19 trial of lead candidate UK biotech Synairgen to begin COVID-19 trial of lead candidate

    Synairgen announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) fast-tracked an approval for the initiation of a trial evaluating its lead candidate ... of NHS trusts and has also been

  • Boehringer Ingelheim forms ‘virtual research’ alliance with MD Anderson Boehringer Ingelheim forms ‘virtual research’ alliance with MD Anderson

    Our Therapeutics Discovery team is well-poised to conduct impactful translational research, and this partnership will allow us to more rapidly advance much-needed new therapies to patients,”said Tim Heffernan, ... Mutations in the KRAS pathway have

  • Merck & Co adds to immunotherapy again with $773m Tilos buy Merck & Co adds to immunotherapy again with $773m Tilos buy

    Dean Li, senior vice president, discovery and translational medicine, Merck Research Laboratories. ... Barbara Fox, chief executive, Tilos. “This agreement with Merck, an industry leader in biopharmaceutical research and development, provides

  • Innovent gears up for PD-1 inhibitor launch in China Innovent gears up for PD-1 inhibitor launch in China

    Innovent hosted a forum this week to highlight the impending availability of Tyvyt as well as the launch of a Clinical Oncology Research Fund, jointly initiated by the Beijing Xisike Clinical ... Oncology Research Foundation, which aims to encourage

  • UCB signs research deal with King’s College London UCB signs research deal with King’s College London

    KCL). Scientists from both UCB and KCL will focus their efforts on early development and translational medicine, with the aim of bringing one novel medicine into clinical trials by the beginning ... our world class expertise in translational research and

More from news
Approximately 2 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    Delivering regenerative medicine from lab to clinic. Today, regenerative medicine is largely confined to a research environment. ... The Cell and Gene Therapy Catapult is also continuing to work to bridge the gap between ‘translational’ research and

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    In 2005, he joined the Novartis Institutes for Biomedical Research as Global Head of Infectious Diseases Translational Medicine and Research. ... In September 2008 he moved to Shanghai as VP for Translational Sciences in Asia for Novartis.

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    LifeArc already has a stake in a broad range of translational research, from investments in small-scale academic research to major drug development alliances with pharma, but now plans a significant ... Lee joined LifeArc from her previous role as chief

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    The last few years have seen the launch of numerous public-private partnerships in translational research partnerships which aim to bridge these gaps and raise the chances of success by pooling ... than ten programmes into preclinical research and

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    The life sciences sector is unquestionably one of the UK’s most important industries: world-class research universities; strength in clinical and translational medicine in the NHS; longitudinal data sets; the ... National Institute for Health Research

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • Mednet Group’s growth spurt

    Rachael is a great new edition to the Mednet Group, the new Account Executive carries an undergraduate degree in Biomedical Science and a research Masters in Translational Oncology. Her interests ... in cancer biology and she has experience working as

  • Adjusting to change in healthcare: Learning from translational research

    Translational research organisations are responding by adjusting their strategies to align with the NHS, to contribute to delivering better patient outcomes, faster. ... Traditionally, the role of translational research is to increase the volume of basic

  • Blue Latitude Health Blue Latitude Health

    Adjusting to change in healthcare: Learning from translational research. ... In this article, Blue Latitude Health's Head of Insight, Martine Leroy, explores how pharma could learn from translational research organisations in adapting their approach to

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Quick links

Infographics

Multimedia